Fortrea Holdings (FTRE) Gross Profit (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Gross Profit came in at $139.2 million in Q2 2026, up 4.27% on a YoY basis from $133.5 million in Q2 2025, and up 12.62% quarter-over-quarter from $123.6 million in Q1 2026.
Analysis
Fortrea Holdings (FTRE) Gross Profit (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has reported Gross Profit for 5 consecutive years, with $139.2 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Gross Profit rose 4.27% year-over-year to $139.2 million; the trailing twelve-month figure through Jun 2026 stood at $516.6 million (down 4.19% YoY), and the FY2025 full-year result was $503.8 million, down 5.69% from the prior year.
- Gross Profit grew to $139.2 million in Q2 2026 per FTRE's latest filing, from $123.6 million in the prior quarter.
- Across five years, Gross Profit topped out at $237.6 million in Q4 2022 and bottomed at $107.9 million in Q1 2024.
- Historically, Gross Profit has averaged $145.6 million across 5 years, with a median of $139.2 million in 2026.
- The sharpest annual moves came in 2023 and 2025: Gross Profit plunged 44.53% in 2023, then climbed 7.97% in 2025.
- Over 5 years, Gross Profit stood at $237.6 million in 2022, then slumped by 44.53% to $131.8 million in 2023, then increased by 6.9% to $140.9 million in 2024, then dropped by 6.96% to $131.1 million in 2025, then advanced by 6.18% to $139.2 million in 2026.
- According to Business Quant data, Gross Profit over the past three periods registered $139.2 million, $123.6 million, and $131.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 139.20 Mn |
| Mar 31, 2026 | 123.60 Mn |
| Dec 31, 2025 | 131.10 Mn |
| Sep 30, 2025 | 122.70 Mn |
| Jun 30, 2025 | 133.50 Mn |
| Mar 31, 2025 | 116.50 Mn |
| Dec 31, 2024 | 140.90 Mn |
| Sep 30, 2024 | 148.30 Mn |
| Jun 30, 2024 | 137.10 Mn |
| Mar 31, 2024 | 107.90 Mn |
| Dec 31, 2023 | 131.80 Mn |
| Sep 30, 2023 | 150.00 Mn |
| Jun 30, 2023 | 156.40 Mn |
| Mar 31, 2023 | 152.40 Mn |
| Dec 31, 2022 | 237.60 Mn |
| Sep 30, 2022 | 167.50 Mn |
| Jun 30, 2022 | 178.80 Mn |